Autopsy report · NCT02999893

A Study of APR-246 in Oesophageal Cancer

“Funding ceased”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 3 years 10 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Peter MacCallum Cancer Centre, Australia

Sponsor type

University, hospital or other

Conditions

Oesophageal Carcinoma

Interventions

APR-246

Participants

5

Sites

5

Countries

Australia

Trials that died the same way

• Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
  “Funding Stopped” (94% match in meaning)
• Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH
  “Funding was stopped” (91% match in meaning)
• Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
  “Funding discontinued” (89% match in meaning)
• Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
  “no longer had funding to continue” (88% match in meaning)
• Evaluating Tumor Pseudoprogression With FLT-PET and MRI
  “Funding ended” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.